Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (471-480 of 626) with videos related to

Pageof 63
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2005
2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitorsMarie-Pierre Lézé, Marc Le Borgne, Pascal Marchand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II studyM E R O'Brien, A Szczesna, H Karnicka, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 27, 2005
Effect of 2-(4-aminophenylmethyl)-6-hydroxy-3, 4-dihydronaphthalen-1(2H)-one on all-trans and 13-cis-retinoic acid levels in plasma quantified by high perfomance liquid chromatography coupled to tandem mass spectrometryMarc Angotti, Rolf W Hartmann, Andrew J Kirby, et al.
Plos One|August 1, 2015
17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine OrthologEmanuele M Gargano, Giuseppe Allegretta, Enrico Perspicace, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2021
Crystalline sponge affinity screening: A fast tool for soaking condition optimization without the need of X-ray diffraction analysisLara Rosenberger, Carolina von Essen, Anupam Khutia, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseasesEmmanuel Bey, Sandrine Marchais-Oberwinkler, Patricia Kruchten, et al.
Klinische Padiatrie|July 1, 1994
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL]A Reiter, M Schrappe, E Yakisan, et al.
Molecular and Cellular Endocrinology|October 14, 2008
The role of the heterocycle in bis(hydroxyphenyl)triazoles for inhibition of 17beta-Hydroxysteroid Dehydrogenase (17beta-HSD) type 1 and type 2Yaseen A Al-Soud, Emmanuel Bey, Alexander Oster, et al.
Steroids|February 28, 2012
Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological propertiesRanju Bansal, Sheetal Guleria, Sridhar Thota, et al.
Journal of Medicinal Chemistry|September 4, 2008
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approachSimon Lucas, Ralf Heim, Matthias Negri, et al.
Pageof 63

Showing results (471-480 of 626) with videos related to

Sort By:
Pageof 63
Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2005
2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitorsMarie-Pierre Lézé, Marc Le Borgne, Pascal Marchand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II studyM E R O'Brien, A Szczesna, H Karnicka, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 27, 2005
Effect of 2-(4-aminophenylmethyl)-6-hydroxy-3, 4-dihydronaphthalen-1(2H)-one on all-trans and 13-cis-retinoic acid levels in plasma quantified by high perfomance liquid chromatography coupled to tandem mass spectrometryMarc Angotti, Rolf W Hartmann, Andrew J Kirby, et al.
Plos One|August 1, 2015
17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine OrthologEmanuele M Gargano, Giuseppe Allegretta, Enrico Perspicace, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2021
Crystalline sponge affinity screening: A fast tool for soaking condition optimization without the need of X-ray diffraction analysisLara Rosenberger, Carolina von Essen, Anupam Khutia, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseasesEmmanuel Bey, Sandrine Marchais-Oberwinkler, Patricia Kruchten, et al.
Klinische Padiatrie|July 1, 1994
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL]A Reiter, M Schrappe, E Yakisan, et al.
Molecular and Cellular Endocrinology|October 14, 2008
The role of the heterocycle in bis(hydroxyphenyl)triazoles for inhibition of 17beta-Hydroxysteroid Dehydrogenase (17beta-HSD) type 1 and type 2Yaseen A Al-Soud, Emmanuel Bey, Alexander Oster, et al.
Steroids|February 28, 2012
Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological propertiesRanju Bansal, Sheetal Guleria, Sridhar Thota, et al.
Journal of Medicinal Chemistry|September 4, 2008
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approachSimon Lucas, Ralf Heim, Matthias Negri, et al.
Pageof 63